ECCO 2023

A focus on surgery and post-operative maintenance

New molecules on the horizon!

JAK inhibitors - small molecules to treat IBD

Long-term duration of response with ozanimod in UC

Prolonged treatment with Ozanimod recaptures remission…

Vedolizumab heals pouch mucosa

Latest update on JAK inhibition

Upadacitinib for fistulizing Crohn´s disease?

S1P modulators in UC

Mucosal healing induced by vedolizumab in chronic…

Upadacitinib is efficacious for UC regardless of…

Medium-term outcome of IBD patients diagnosed at…

No impact of previous therapies for Upadacitinib in…

Upadacitinib works in bionaive and bio-exposed pts in…

Update zu JAK-Inhibitoren bei CED

S1P-Modulatoren bei Colitis ulcerosa

Lang Termijn respons met ozanimod bij colitis ulcerosa

Studio lungo termine di ustekinumab in UC

Upadacitinib: Vortherapien spielen keine Rolle mehr bei…

Il prolungamento del trattamento con Ozanimod induce…

Upadacitinib is efficient bij colitis ulcerosa,…

Anti-IL23 drugs: is it all the same?

New aspects on safety of anti-TNF treatment

Safety update on JAKis - new worries?

Positive effects of Upadacitinib on resolution of…

Risk of IBD from early antibiotic exposure in live

Ileostomy with better prognosis than pouch in PSC

Etrasimod shows fast stool frequency and rectal…

Το upadacitinib επιφέρει ύφεση των κοιλιακών…

Ozanimod shows good efficacy and safety profile after…

Rapido controllo del sanguinamento rettale e della…

Les antibiotiques dans la petite enfance augmentent le…

Practice-changing data on surgery in CD and UC

Surgery in CD - resetting or not?

Post-surgical Crohn's disease

Another clue for the role of the microbiome in PSC?

Peri- and postoperative management of CD

New drugs on the block!

Is it feasible to stop anti-TNF treatment in…

Vedolizumab prevents postoperative recurrence in CD

Biologics in CD – is earlier better?

Ileocaecal Crohn's disease - should we call the surgeon…

Vedolizumab for preventing postoperative reccurence of…

Epigenetic fingerprinting - a novel tool for precision…

Timing of surgery in Crohn's disease

Enteral nutrition - food for thought!

Surgical and post-operative management in CD

DNA methylation predicts response to biologics in IBD

Early treatment with biologics in IBD

Είναι ευχερές να διακόψουμε τους αντι-TNF παράγοντες…

Résection chirurgicale au course de la maladie de…

Aanpak van de (post)operatieve Crohn patient

Biologics in CD - is earlier better?

Vedolizumab previene la recidiva post operatoria nei…

Vedolizumab en prévention de la récidive postopératoire…

Postać ileocekalna choroby Crohna - czy chirurgia ma…

Another clue for the role of the microbiome in PSC?

Biosimilars

Peri- und postoperatives Management bei Morbus Crohn

Résection chirurgicale précoce dans la MC

Chirurgischer Verlauf nach Morbus Crohn

Neue Substanzen!

Comprehensive remission - the new standard!?

Comprehensive Disease Control

New ECCO guidelines on extraintestinal manifestations…

Our patients will be better off in the near future!

Sequencing in IBD - congress overview

GPX4 fueling postoperative recurrence in Crohn's…

New opportunities from the application of artificial…

Comprehensive overview of surgery in IBD

Una vida mejor en el futuro inmediato para nuestros…

Panoramica completa sulla chirurgia nelle malattie…

Nuove opportunità dall’applicazione dell’intelligenza…

Sequencing nelle malattie infiammatorie cronicale…

Nowe wytyczne ECCO dotyczące manifestacji…

Mucosal signatures suggest a mechanism for early CD…